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Natural killer (NKT) T cells exhibit tissue distribution, surface phenotype, and functional
responses that are strikingly different from those of conventional T cells. The transcrip-
tion factor PLZF is responsible for most of these properties, as its ectopic expression in
conventional T cells is sufficient to confer to them an NKT-like phenotype. The molecular
program downstream of PLZF, however, is largely unexplored. Here we report that PLZF
regulates the expression of a surprisingly small set of genes, many with known immune
functions. This includes several established components of the NKT cell developmental
program. Expression of the transcriptional regulators Id2, previously shown to be required
for iNKT cell survival in the liver and c-Maf, which shapes the NKT cytokine profile, was
compromised in PLZF-deficient cells. Ectopic expression of c-Maf complemented the cells’
defect in producing IL-4 and IL-10. PLZF also induced a program of cell surface receptors
which shape the NKT cell’s response to external stimuli, including the costimulatory recep-
tor ICOS and the cytokine receptors IL12rb1 and IL18r1. As an ensemble, the known
functions of the molecules whose expression is affected by PLZF explain many defects
observed in PLZF−/− NKT cells.
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INTRODUCTION
Multiple T cell lineages develop in the thymus from common prog-
enitors. Most T lymphocytes – so called conventional T cells – exit
the thymus in the “naïve” state. After activation by cognate anti-
gen they take days to differentiate into effector cells capable of
cytokine secretion and cytotoxic responses. Several T cell subsets,
however, acquire effector functions already in the thymus – pre-
sumably because they encounter TCR ligands but escape deletion
(Baldwin et al., 2004). Such cells exhibit rapid effector responses
resembling those of innate immune cells (e.g., natural killer; NK
cells), and are thus called “innate-like” T cells. They are believed
to represent the first line of defense against pathogens, and to
provide cytokines that regulate subsequent immune responses by
conventional T cells.
Exactly how innate-like T cells acquire their peculiar prop-
erties is poorly understood. Perhaps the best studied subset of
innate T lymphocytes are the invariant natural killer T (iNKT)
cells. In mice, they express an αβ T cell receptor (TCR) that con-
sists of the invariant Vα14-Jα18 TCRα chain coupled with TCRβ
chains of limited diversity, and recognize lipid antigens in the
context of the MHC class I-like molecule CD1d. Many iNKT
cells express cell surface markers typical of NK cells, including
NK1.1, but can also express the CD4 coreceptor, and, like other
innate-like T cells, exhibit in the absence of deliberate activation a
surface phenotype characteristic of activated conventional T cells.
Upon activation, iNKT cells rapidly secrete a unique spectrum of
cytokines. Specifically, they can co-produce IFNγ and IL-4 – i.e.,
cytokines secreted by discrete subsets of conventional T cells –
Th1 and Th2 cells, respectively. Another key feature differentiating
NKT cells from conventional T cells is their ability to produce
cytokines in response to proinflammatory stimuli in the absence
of foreign antigen – a property that is dependent on signaling by
IL-12 (Brigl et al., 2003, 2011), IL-18 (Nagarajan and Kronenberg,
2007; Velazquez et al., 2008), or type I interferon (Paget et al., 2007)
receptors. Unlike naïve conventional T cells, which home to spleen
and lymph nodes, iNKT cells accumulate in the liver, but are also
present in the spleen and, to a lesser extent, lymph nodes.
A subset of γδ T cells that express the Vγ1Vδ6.3/Vδ6.4 TCR
exhibits properties resembling those of iNKT cells (Azuara et al.,
1997; Lees et al., 2001). Unlike most other γδ T cells, they often
express NK1.1 and CD4, home to the liver, can co-produce IL-
4 and IFNγ, and depend on the same transcriptional program as
iNKT cells (Azuara et al., 1997; Lees et al., 2001; Alonzo et al., 2009;
Kreslavsky et al., 2009; see below). Thus, they are often referred to
as γδNKT cells.
Significant advances were made in understanding the transcrip-
tional network that regulates NKT cell development. A plethora
of transcription regulators including, but not restricted to GATA3,
T-bet, ThPOK, Id2, Runx1, Tox, c-Myc, Egr2, and c-Maf were
implicated in iNKT cell development, function, and/or homeosta-
sis (reviewed in D’Cruz et al., 2010; Godfrey et al., 2010). Recently
it was reported that the transcription factor PLZF (promyelocytic
leukemia zinc finger), previously implicated in limb patterning
(Barna et al., 2000) and spermatogonial stem cell self-renewal
(Buaas et al., 2004), was required for iNKT cell development. In
the absence of PLZF, CD1d-restricted iNKT cells were present, but
their numbers were severely reduced in the thymus, spleen, and
liver (Kovalovsky et al., 2008; Savage et al., 2008). iNKT cells in
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PLZF-deficient mice resembled conventional T cells because of
their reduced expression of activation markers and diminished
ability for rapid cytokine production (Kovalovsky et al., 2008;
Savage et al., 2008). Similar changes were documented for PLZF-
deficient γδNKT cells (Alonzo et al., 2009; Kreslavsky et al., 2009).
The observation that PLZF could be induced by TCR crosslink-
ing in polyclonal TCRγδ+ thymocytes (Kreslavsky et al., 2009)
suggested that PLZF induction may require the encounter of TCR
ligands in the thymus. Indeed, a novel reporter mouse suggests that
NKT cells undergo strong TCR signaling at an early stage of their
development (Moran et al., 2011); consistently, Egr2 downstream
of the TCR has been shown to activate PLZF expression (Seiler
et al., 2012). Strikingly, transgenic PLZF expression in conven-
tional T cells was sufficient to confer to them many NKT cell prop-
erties (Raberger et al., 2008; Savage et al., 2008, 2011; Kovalovsky
et al., 2010). Thus PLZF appears both necessary and sufficient for
the acquisition of many NKT cell-like properties by a conventional
T cell – and seems to be absolutely unique in this respect.
PLZF expression by NKT and NKT-like cells also has a far-
reaching influence on other immune cells. Mice deficient in Itk
(Felices et al., 2009; Qi et al., 2009), Id3 (Lauritsen et al., 2009;
Ueda-Hayakawa et al., 2009; Verykokakis et al., 2010a), and KLF2
(Odumade et al., 2010), as well as mice with mutated SLP-
76 (Alonzo et al., 2009) and mice transgenic for Dok-1 (Besin
et al., 2012) have increased numbers of PLZF-expressing cells – a
phenomenon yet to be explained. IL-4 secretion by these PLZF-
expressing cells leads to acquisition of innate-like features by CD8
T cells (Verykokakis et al., 2010b; Weinreich et al., 2010; Gordon
et al., 2011). The increased frequency of innate-like CD8 T cells in
wt BALB/c mice likewise depends on IL-4 produced by NKT cells
(Verykokakis et al., 2010b; Weinreich et al., 2010; Lai et al., 2011).
Even though the defects in the NKT cell compartment of PLZF-
deficient mice are well-defined, little is known about the molecular
program downstream from PLZF. Here we demonstrate that PLZF
regulates the expression of a very restricted set of genes, many of
which have known immune function. This includes known regula-
tors of NKT cell development, function, and homeostasis: the tran-
scription factor c-Maf, required for IL-4 production (Kim et al.,
1999); the inhibitor of E protein signaling Id2, required for sur-
vival and accumulation of NKT cells in the liver (Monticelli et al.,
2009); the receptor ICOS (inducible T cell costimulator), required
for accumulation of NKT cells in thymus, spleen, and liver, as well
as for cytokine responses (Akbari et al., 2008; Chung et al., 2008;
Watanabe et al., 2010); and the cytokine receptors IL12rb1 and
IL18r1, required for effector responses in the absence of foreign
antigen (Brigl et al., 2003, 2011; Nagarajan and Kronenberg, 2007;
Velazquez et al., 2008). The known, NKT cell-specific functions of
these molecules can explain to a large extent the abnormal NKT
cell phenotype of PLZF-deficient animals with respect to tissue
distribution, secretion of and responsiveness to cytokines.
MATERIALS AND METHODS
MICE
Luxoid mice that bear a point mutation in the PLZF gene (Buaas
et al., 2004) and phenocopy the PLZF knockout in the NKT com-
partment (Kovalovsky et al., 2008; Savage et al., 2008; backcrossed
for more than 35 generations to C57BL/6) were obtained from
the Jackson Laboratory. C57BL/6 and CD45.1 C57BL/6 mice were
obtained from the Jackson Laboratory and Taconic, respectively.
Rag1−/− Vγ1Vδ6.4 TCR transgenic mice were described previ-
ously (Kreslavsky et al., 2009). All mice were bred and maintained
in the animal facility at the Dana-Farber Cancer Institute (DFCI).
All animal procedures were done in compliance with the guidelines
of the DFCI Animal Resources Facility, which operates under reg-
ulatory requirements of the U.S. Department of Agriculture and
the Association for Assessment and Accreditation of Laboratory
Animal Care.
FLOW CYTOMETRY AND CELL SORTING
mAbs specific for CD4 (RM4-5), CD8a (53-6.7), TCRβ (H57-
597), TCRγδ (GL3), NK1.1 (PK136), CD24 (M1/69), CD44
(IM7), CD45.1 (A20), CD45.2 (104), ICOS (C398.4A and 15F9),
Vδ6.3 (8F4H7B7), IL12Rβ1 (114), IL18R1 (BG/IL18RA), IFNγ
(XMG1.2), CXCR6 (221002), IL-10 (JES5-16E3), and IL-4 (BVD6-
24G2) were purchased from BD Biosciences, eBioscience, R&D
Biosystems, or Biolegend and were used as fluorescein isothio-
cyanate (FITC), phycoerythrin (PE), peridinin chlorophyll protein
(PerCP), PerCP-Cy5.5, PE-Cy7,allophycocyanin (APC),APC-Cy7,
Alexa-Fluor® 647, or Pacific Blue conjugates. PLZF antibody (D-
9) was purchased from Santa Cruz Biotechnology and conjugated
to Alexa-Fluor 647 using a kit from Invitrogen. For intracel-
lular PLZF detection cells were fixed and permeabilized using
the eBioscience Foxp3 Staining Buffer Set. PE and Pacific Blue
labeled PBS-57-loaded CD1d tetramers were obtained from the
NIH Tetramer Facility. For cytokine production cells were stim-
ulated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA)
and 500 ng/mL ionomycin for 5 h with brefeldin A (3µg/mL)
added after 1 h of incubation, or left unstimulated. Cells were
then stained for surface markers, fixed, permeabilized using the
BD Cytofix/Cytoperm kit and stained for intracellular cytokines.
Flow cytometry and cell sorting was performed on a FACSAria
(BD Biosciences) cell sorter. Data were analyzed using FlowJo
(Treestar).
RETROVIRAL INFECTIONS
Full-length protein-coding c-Maf (Ensembl transcript ID ENS-
MUST00000109104) cDNA was cloned into pMIG retroviral vec-
tor (Addgene). Retrovirus-containing supernatants were gener-
ated by transient co-transfection of 293T cells with pMIG based
constructs and packaging vector pCL-Eco (Addgene). Super-
natants were harvested on day 4 and concentrated on centrifugal
filtration devices (100 kDa cutoff; Millipore). Cells were spin-
infected (1.5 h, 500 g) on plates coated with RetroNectin (Takara)
in the presence of 8µg/mL polybrene (Sigma).
NKT CELL CULTURES
CD1d-PBS57-Tet+ cells were sorted from WT and luxoid mice
and cultured for 2 days in the presence of 10 ng/mL IL-7 (R&D
Systems) and 100 ng/mL IL-15 (Peprotech). Cells were then spin-
infected with c-Maf-encoding or control retroviruses as described
above in the presence of IL-7 and IL-15. Two days after infection
cells were washed, stimulated with PMA/ionomycin and stained
for intracellular cytokines as described above. For cytokine stimu-
lation, 10 ng/mL IL-12 and/or 100 ng/mL IL-18 (Peprotech) or
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plates coated with 10µg/mL CD3e antibody (145-2C11) were
used. IFNγ in culture supernatants was measured using the mouse
IFNγ OptEIA kit (BD Pharmingen).
GENERATION OF MIXED BONE MARROW CHIMERAS
Bone marrow cells from CD45.1 C57BL/6 and CD45.2 luxoid
mice were stained with CD4, CD8α, TCRβ, TCRγδ, and NK1.1
biotinylated antibodies followed by incubation with streptavidin-
conjugated magnetic beads (Invitrogen) and magnetic bead deple-
tion of T and NK cells. CD45.1 C57BL/six recipients were the
subject of lethal irradiation (1000 rads) using a γ-cell 40 irra-
diator with a cesium source. Mixed (1:1) T cell- and NK-cell-
depleted wt and PLZFlu/lu bone marrow cells (4–8× 106) were
intra-orbitally injected into the recipient mice. Chimeras were
used in experiments 5 weeks or more after the bm transfer.
MICROARRAYS
CD4+CD8α− thymocytes from Vγ1Vδ6.4 transgenic mice on
Rag1−/− PLZFlu/lu, PLZFlu/+, and PLZF+/+ backgrounds were
double-sorted, with the second sort directly into TRIzol reagent
(Invitrogen). Total RNA was prepared and submitted to the
microarray core facility at the DFCI. There labeled cDNA was pre-
pared and hybridized to Affymetrix Mouse Gene 1.0 ST Arrays.
Data processing and analysis was performed using the GenePat-
tern v3.21 package (http://genepattern.broadinstitute.org) using
ExpressionFileCreator, MultiplotPreprocess, and Multiplot mod-
ules. Probe sets corresponding to normalization controls were
filtered out prior to the analysis. Data have been submitted to
GEO (accession number GSE42168). For comparison shown in
Figure 1C dataset from Immgen database (Heng and Painter,
2008) was used (GEO accession number GSE15907).
QUANTITATIVE PCR
Indicated populations were double-sorted, with the second sort
directly into TRIzol reagent (Invitrogen). Total RNA was prepared
and cDNA was synthesized using Superscript III reverse transcrip-
tase (Invitrogen) according to the manufacturer’s recommenda-
tions. Real-time RT-PCR was performed on an ABI PRISM ther-
mal cycler (Applied Biosystems) using TaqMan PCR mastermix
(Applied Biosystems). Mm02581355_s1 (Maf), Mm00711781_m1
(Id2), and Mm99999915_g1 (GAPDH) TaqMan Gene Expression
Assays (Applied Biosystems) were used.
RESULTS
PLZF REGULATES A FOCUSED PROGRAM OF FACTORS IMPORTANT FOR
NKT CELL FUNCTION
To dissect PLZF-dependent regulation of NKT cells at the mole-
cular level we aimed to compare gene expression profiles of cells
from WT and PLZF-deficient luxoid (PLZFlu/lu) mice (Savage et al.,
2008). However, both iNKT (Kovalovsky et al., 2008; Savage et al.,
2008) and γδNKT (Alonzo et al., 2009) cell numbers are very
low in the PLZF-deficient animals, and the residual cells may be
the product of selection of an NKT subpopulation, and therefore
may not be directly comparable to wt counterparts (Savage et al.,
2008). To circumvent these problems we crossed luxoid animals
to mice transgenic for a γδNKT TCR (Vγ1Vδ6.4), which was pre-
viously shown to generate large numbers of PLZF-expressing T
cells (Kreslavsky et al., 2009). Since the phenotypes of γδNKT and
iNKT cells were very similar in PLZFlu/lu animals, the molecular
program downstream of PLZF in these subsets should overlap to
a great extent.
The gross thymic phenotype of Rag1−/−γδTCR transgenic
PLZFlu/lu, PLZFlu/+, and PLZF+/+ animals – including thymic
cellularity and the frequency of CD4−CD8−, CD4+CD8+, and
CD4+CD8− cells – was very similar (Figure 1A). From this we
concluded that there was no evidence for selection of a subpopu-
lation in these mice, and proceeded to compare γδNKT cells from
TCR transgenic PLZF-sufficient and PLZF-deficient mice. We pre-
viously demonstrated that PLZF in the γδTCR transgenic mice was
expressed by the majority (78.8± 3.9%) of CD4+CD8− thymo-
cytes, and that PLZF upregulation required the expression of the
TCR transgene (Kreslavsky et al., 2009). The CD4+ phenotype of
γδNKT cells was not surprising, since a large fraction of both αβ
and γδNKT cells in wt mice express CD4 (Azuara et al., 1997).
Gene expression profiles of CD4+CD8− thymocytes from
Rag1−/− Vγ1V δ6.4 transgenic mice on PLZFlu/lu, PLZFlu/+, or
PLZF+/+ backgrounds were compared using Affymetrix Mouse
Gene 1.0 ST chips. Since without PLZF NKT cells resemble naïve T
cells in their surface phenotype and functional properties (Koval-
ovsky et al., 2008; Savage et al., 2008) and since ectopic PLZF
expression is sufficient to confer memory/effector properties to
conventional T cells in the absence of agonist TCR signaling
(Raberger et al., 2008; Kovalovsky et al., 2010; Savage et al., 2011),
we expected to find differences in expression of many genes, com-
parable to the differences between conventional T cells and NKT
cells. Strikingly, however only 146 probe sets exhibited more than
a twofold difference between PLZFlu/lu and PLZF+/+ thymocytes,
compared to over a thousand probe sets between wt CD4SP thy-
mocytes and wt stage 1 NKTs (Figures 1B,C). A number of genes
with known immune function were expressed at higher levels in
the presence of PLZF. These include genes for chemokine recep-
tors Ccr2, Ccr10, and Il8rb, cytokine receptors Il12rb1 and Il18r1,
transcription regulators Id2, Zbtb7b (encodes ThPOK), and Maf
(encodes c-Maf), as well as costimulatory molecules Icos and
Cd40lg (Figure 1B; Table S1 in Supplementary Material). Among
genes that were downregulated in the presence of PLZF were
Il4ra, Ifngr1, Stat4, Il6st, and Cd8b1 (Figure 1B and Table S2 in
Supplementary Material). Many PLZF-regulated genes from our
analysis were differentially expressed between iNKT and CD4+
thymocytes (Figure 1C), consistent with our gene set representing
the NKT molecular program. Since Id2 (Monticelli et al., 2009),
c-Maf (Kim et al., 1999), as well as ICOS (Akbari et al., 2008;
Chung et al., 2008; Watanabe et al., 2010), IL12R (Brigl et al., 2003,
2011), and IL18R (Nagarajan and Kronenberg, 2007; Velazquez
et al., 2008) signaling pathways had previously been implicated
in NKT cell development, homeostasis and/or function, we pro-
ceeded to validate these targets in iNKT and γδNKT cells from wt
and PLZF-deficient mice that did not express TCR transgenes.
PLZF/C-MAF AXIS CONTROLS IL-4 AND IL-10 PRODUCTION
Strong reduction in IL-4 and IL-10 production by NKT cells
is a characteristic feature of the PLZF−/− phenotype (Koval-
ovsky et al., 2008; Savage et al., 2008). The transcription factor
c-Maf is required for IL-4 production by Th2 and NKT cells
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FIGURE 1 | Cell surface phenotype and gene expression profiles of
thymocytes from PLZF sufficient and PLZF-deficientTCR transgenic
mice. (A) Thymocytes from Rag1−/−Vγ1Vδ6.4 TCR transgenic animals on
PLZF+/+, PLZFlu/+, and PLZFlu/lu backgrounds were stained with antibodies
against CD4 and CD8α and analyzed by FACS. Absolute numbers of
thymocytes are indicated. Representative FACS plots from one of two
independent experiments are shown. (B) Expression profiles of PLZF+/+
versus PLZFlu/lu double-sorted CD4+CD8− thymocytes from
Rag1−/−Vγ1Vδ6.4 TCR transgenic animals were compared. Expression
values of PLZFlu/lu (X axis) against PLZF+/+ (Y axis) cells are plotted. Blue
lines indicate twofold difference thresholds in expression between PLZF+/+
and PLZFlu/lu thymocytes. Numbers in blue indicate the number of probe
sets above the upper line and below the lower line. Some of the
immunologically relevant genes are highlighted and labeled. (C)
Expression values of conventional CD4 thymocytes (X axis) against stage
1 NKT cells (Y axis) from Immgen database are plotted. Genes positively
regulated by PLZF above the twofold threshold in (B) are highlighted in
red, those regulated negatively – in blue. Blue lines indicate twofold
difference thresholds in expression. Numbers in blue indicate the number
of probe sets above the upper line and below the lower line.
(Ho et al., 1996; Kim et al., 1999), and was shown to regu-
late IL-10 expression in Th17 and Tr1 cells (Xu et al., 2009b;
Apetoh et al., 2010). We thus measured c-Maf expression in
TCR non-transgenic iNKT and γδNKT cells. To exclude non-cell
autonomous effects of PLZF deficiency, this was done in mixed
bm chimeras. PLZFlu/lu iNKT and γδNKT cells exhibited a signifi-
cant reduction in c-Maf expression (Figure 2A). The level of c-Maf
was close to that in conventional CD4 thymocytes (Figure A2A in
Appendix).
It was suggested that iNKT cells in PLZF-deficient mice did not
progress beyond stage 1 (NK1.1−CD44−) in their development
(Savage et al., 2008) and thus the observed differences in gene
expression may result from this developmental block (arguments
for and against this block are discussed later). Thus we compared
c-Maf expression in CD1d tetramer binding NK1.1−CD44− thy-
mocytes (includes stage 0 and stage 1 iNKT cells). Although the
overall level of c-Maf expression was lower in these cells when com-
pared to total iNKT cells, the reduction was obvious (Figure 2B).
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FIGURE 2 | PLZF regulates the expression of c-Maf. Expression of Maf was
analyzed by TaqMan qPCR in sorted total thymic, splenic, and liver iNKT
(TCRβ+CD1d-Tet+) and γδNKT (TCRγδ+Vδ6.3+) cells (A) or in stage 0/stage 1
iNKT cells (CD44−NK1.1−TCRβ+CD1d-Tet+) (B) from mixed bm chimeras.
Mean relative c-Maf expression normalized against GAPDH expression is
shown. Error bars represent SD (individual mice). Statistical significance is
indicated where reached. iNKT cell were sorted from thymi (C) and spleens
(D,E) of WT or PLZFlu/lu mice, cultured for 2 days in the presence of IL-7 and
IL-15, infected with IRES-GFP or c-Maf-IRES-GFP retroviruses and stimulated
with PMA/Ionomycin 2 days after infection. Expression of IFNγ and IL-4 in
GFP+ cells (C,D) as well as IL-10 and GFP in all NKT cells (E) is shown.
Representative FACS plots from one of two (C) and one of three (D,E)
experiments are shown. Histogram overlays comparing cytokine production
by wt and lu/lu cells in response to c-Maf expression are shown for (D).
Thus PLZF is required for the upregulation of c-Maf before the
putative stage 1 developmental block.
We next tested whether c-Maf expression could complement
cytokine production defects in PLZF-deficient NKT cells. Due to
the extremely low number of γδNKT cells in PLZFlu/lu animals we
focused on iNKT cells for this experiment. As premature expres-
sion of c-Maf can lead to a block in T cell development (Morito
et al., 2006) we sought to restore c-Maf expression in mature iNKT
cells. To this end, sorted iNKT cells from wt and PLZFlu/lu ani-
mals were infected with c-Maf-IRES-GFP or control IRES-GFP
retroviruses. Cells were then stimulated with PMA/ionomycin,and
production of IL-4, IFNγ, and IL-10 was assessed. In thymic iNKT
cells, ectopic c-Maf expression rescued IL-4 production by PLZF-
deficient cells and further increased the level of IL-4 per cell in wt
iNKT cells (Figure 2C). The same trend was observed in splenic
iNKT cells (Figure 2D), although some IL-4 was already produced
by stimulated PLZFlu/lu splenic iNKT cells – presumably because
of IL-7 and IL-15 in culture. Likewise, ectopic c-Maf expression
rescued IL-10 production by PLZF-deficient splenic iNKT cells,
and further enhanced IL-10 production by their wt counterparts
(Figure 2E). c-Maf overexpression somewhat reduced the produc-
tion of IFNγ (Figure 2D), consistently with previous reports for
conventional T cells (Ho et al., 1998). However, the frequency
of IFNγ/IL-4 dual producers – a population most affected by
PLZF deficiency – was reproducibly increased by ectopic c-Maf
expression in splenic wt iNKT cells.
Thus the expression of c-Maf, a transcription factor that reg-
ulates cytokine production, is induced by PLZF and its ectopic
expression is sufficient to rescue IL-4 and IL-10 production by
PLZF-deficient iNKT cells.
PLZF IS REQUIRED FOR APPROPRIATE EXPRESSION OF Id2 IN NKT
CELLS
In PLZF-deficient mice, the reduction in the NKT compartment
in the liver is more dramatic than that in the thymus and spleen
(Savage et al., 2008), suggesting that the former is not simply a
result of the latter.
Mice deficient for an inhibitor of E protein signaling – Id2 –
were recently demonstrated to have about 10-fold lower numbers
of NKT cells in the liver – but not in the spleen or thymus (Mon-
ticelli et al., 2009). The phenotype was attributed to cell survival.
A recent report suggests that Id2 is a direct PLZF target in myeloid
cells (Doulatov et al., 2009). Thus we tested whether Id2 expres-
sion depends on PLZF in NKT cells from mice that did not express
a TCR transgene.
PLZF-deficient thymic and splenic iNKT and γδNKT cells
(Figure 3A) from mixed bone marrow chimeras exhibited a
twofold to threefold reduction in Id2 transcripts when compared
to wt cells. Both PLZFlu/lu and wt stage 0/1 NKT cells exhibited
comparably low levels of Id2 expression (Figure 3B). Interestingly,
the residual PLZF-deficient NKT cells from the liver exhibited
a normal level of Id2 expression. As Id2 was shown to control
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FIGURE 3 | PLZF regulates the expression of Id2. Expression of Id2
was analyzed by TaqMan qPCR in sorted total thymic, splenic, and liver
iNKT (TCRβ+CD1d-Tet+) and γδNKT (TCRγδ+Vδ6.3+) cells (A) or in stage
0/1 iNKT cells (CD44-NK1.1-TCRβ+CD1d-Tet+) (B) from mixed bm
chimeras. Mean relative Id2 expression normalized against GAPDH
expression is shown. Error bars represent SD (individual mice). Statistical
significance is shown where reached. (C) CXCR6 expression was
analyzed on wt (CD45.1) or PLZFlu/lu (CD45.2) iNKT (TCRβ+CD1d-Tet+)
cells from the thymus, spleen, and liver of bm chimeric mice. Percent
CXCR+ and CXCRhi are indicated.
survival of hepatic NKT cells, this result may indicate selection for
cells with a normal level of expression.
Id2−/− NKT cells also show decreased expression of
CXCR6, a receptor important for homing and accumulation
of iNKT cells in the liver (Monticelli et al., 2009). Con-
sistently, PLZF-deficient iNKT cells in spleen and liver had
a much reduced CXCR6hi population (Figure 3C). Some
CXCR6hi cells remained in the thymus, however, perhaps
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explaining why CXCR6 was not differentially expressed on our
microarray.
ICOS EXPRESSION IN NKT CELLS IS AFFECTED BY PLZF
Many features of the PLZF−/− phenotype – such as reduced NKT
cell numbers in spleens and livers, a defect in production of
cytokines – including, but not restricted to IFNγ and IL-4 – were
also reported for mice deficient in the costimulatory molecule
ICOS or for its ligand (Akbari et al., 2008; Chung et al., 2008;
Watanabe et al., 2010), albeit these traits were less pronounced in
ICOS−/− and ICOSL−/− mice than in PLZF−/− animals. Like in
the case of PLZF deficiency, this was at least in part a developmen-
tal defect, rather than merely a defect in activation due to the lack
of costimulation, as a partial block in iNKT cell differentiation
was observed (Chung et al., 2008). Interestingly, ICOS and PLZF
exhibited correlated expression in iNKT cells (Figure 4A), sug-
gesting that PLZF was a limiting factor in the regulation of ICOS
expression in NKT cells. In the thymus a fraction of PLZFhi NKT
cells expressed very high levels of ICOS. PLZFhi cells correspond
to immature stages 1 and 2 of NKT cell development (Kovalovsky
et al., 2008) – and thus NKT cells progress through a PLZFhiICOShi
stage early in their differentiation.
As the phenotypes of ICOS−/− and ICOSL−/− animals were
reminiscent of the PLZF knockout, we next measured the expres-
sion of ICOS in PLZF-deficient, PLZF-heterozygous, and wt mice.
ICOShi cells, which were readily detectable among both iNKT and
γδNKT WT thymocytes, predominantly within the CD4+ pop-
ulation, were completely absent in the PLZFlu/lu thymi. ICOSint
iNKT and γδNKT cells were present at a comparable frequency
in the thymus (Figure 4B). PLZFlu/+ iNKT thymocytes contained
an abnormally high percentage of ICOShi cells (Figure 4B) – a
finding explained by the fact that in these animals a large num-
ber of cells appear blocked at the ICOShi stage 2 (Figure A1A in
Appendix). In the periphery (Figures 4C,D) the ICOShi popula-
tion was not detectable, consistent with the fact that they represent
immature cells. However, expression of ICOS on peripheral iNKT
and γδNKT cells was dramatically reduced in PLZF-deficient cells,
resulting in a strong reduction in ICOSint cells in the spleen
(Figure 3C) and liver (Figure 4D). Notably, the regulation of
ICOS by PLZF was evident even in early thymic stage 0/1 iNKT
cells (Figure 4E), suggesting that the effect was independent of any
possible developmental block.
PLZF PROGRAMS NKT CELLS TO RESPOND TO A DISTINCT SET OF
CYTOKINES
About 7% of the genes whose expression was affected by PLZF
twofold or more are cytokine/chemokine receptors and down-
stream components of cytokine receptor signaling: Il18r1, Il8rb,
Il12rb, Ccr2, Ccr10, Irak3 are upregulated, while Stat4, Il4ra, Il6st,
and Ifngr1 are downregulated by PLZF. This statistically signifi-
cant (p= 2.7× 10−5, DAVID functional annotation tool; Huang
et al., 2008) enrichment suggests that PLZF programs NKT cells
to respond to a distinct set of extracellular stimuli. IL18R and
IL12R signaling was previously implicated in foreign antigen-
independent effector responses, where NKT cells were capable
of effector cytokine responses without exogenous antigen stim-
ulation. Expression of both IL12Rb1 and IL18R1 on iNKT cells
was dramatically decreased in the absence of PLZF – as judged by
staining of thymocytes from mixed bm chimeras (Figures 5A,B).
Importantly, this difference was obvious as early as stage 0/1. A
similar decrease in IL18R1 but not in IL12Rb1 was observed in
γδNKT cells (Figures 5A,B).
Although a general defect in IFNγ production by PLZF-
deficient NKT cells has been reported (Kovalovsky et al., 2008;
Savage et al., 2008), in case of stimulation by IL-12 and IL-18 the
defect may be compounded by low receptor expression. Consistent
with this idea, PLZF-deficient cells were incapable of an adequate
response to IL-12 and IL-18 cytokines. Wt but not PLZFlu/lu TCR
transgenicγδNKT cells were able to produce a high level of IFNγ in
response to a combination of IL-12 and IL-18 (Figure 5C). A sim-
ilar, though less complete defect was observed in PLZFlu/lu iNKT
cells (Figure 5D). Decreased IFNγ secretion may be not only the
result of an intrinsic effect, but also of the dramatically reduced
levels of IL-12 and IL-18 receptor expression (Kovalovsky et al.,
2008; Savage et al., 2008).
Wt cells also robustly upregulated CD25 in response either to
IL-12 or anti-CD3 stimulation. In contrast, PLZFlu/lu iNKT cells
reacted to anti-CD3 but not to IL-12 (Figure 5E), showing that
the modulation of IL12Rb1 expression by PLZF is essential for the
responsiveness of iNKT cells to IL-12.
DISCUSSION
We show here that PLZF, a key transcription factor whose expres-
sion is sufficient to confer NKT-like cell surface phenotype, hom-
ing pattern, and cytokine secretion profile to conventional T cells,
regulates an unexpectedly small set of genes. However, at least 29
out of the 146 genes whose expression changed twofold or more
had known immunological functions (DAVID functional annota-
tion tool; Huang et al., 2008). Some of these genes are known to be
important for NKT cell development, homeostasis and function –
and together explain a part of the PLZF-deficient NKT cell phe-
notype. Although our expression profiling compared total TCR
transgenic Rag -deficient γδNKT thymocytes, in order to address
the danger that PLZF-deficient iNKT cells may be the products
of selection – most differences were reproduced in wt NKT cells,
at the earliest developmental stage where PLZF is expressed and
prior to any possible developmental block due to PLZF deficiency.
While rapid production of effector cytokines in response to
TCR and cytokine stimulation is a hallmark property of NKT cells,
we found that, unexpectedly, at least at steady state, the expres-
sion of cytokine genes was not dramatically changed in PLZFlu/lu
thymocytes: Ifng, Il10, Il4, Il13, and Tnf were regulated less than
twofold. The observed changes at the protein level may occur post-
translationally, or may become evident only upon activation of the
cell. PLZF-regulated genes in T cells showed no obvious overlap
with genes induced by ectopic PLZF expression in a human mono-
cytic cell line (Xu et al., 2009a), suggesting that cell type-specific
context can influence the set of PLZF targets.
On the other hand, expression of several cytokine and
chemokine receptors, as well as molecules involved in downstream
signaling from these receptors were affected – suggesting that PLZF
in some cases acts to program the cell’s trafficking pattern and to
shape its response to environmental signals, rather than changing
the cell intrinsically. Of particular importance are the receptors
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FIGURE 4 | PLZF regulates the expression of ICOS. Cells from thymus,
spleen and liver were stained with CD1d-PBS-57 tetramers and antibodies
against ICOS and CD4, fixed, permeabilized, stained with anti-PLZF and
analyzed by FACS (A). Results are depicted as an overlay of ICOS/PLZF
plots for CD4+CD1d−Tet− (green) and CD1d-Tet+ cells (red). Cells from
thymi (B), spleens (C), and livers (D) of PLZFlu/lu, PLZFlu/+, and PLZF+/+
mice were stained with PBS-57-loaded CD1d tetramers and antibodies
against TCRβ, TCRγδ, Vδ6.3, CD4, and ICOS, and analyzed by FACS. Gating
scheme for WT cells is shown (left). Expression of CD4 and ICOS on
TCRβ+CD1d-tet+ and TCRγδ+Vδ6.3+ cells is shown for mice with each
genotype (right). Gates are set on ICOSint and ICOShi cells. Expression of
ICOS on thymic stage 0/stage 1 iNKT cells
(CD44−NK1.1−TCRβ+CD1d-Tet+) is shown. (E) Representative FACS plots
from one of three independent experiments are shown.
for IL-12 and IL-18, which in concert mediate a unique part of
the NKT cell program – the ability to produce effector cytokines
without stimulation with foreign antigen. We show that in the
absence of PLZF both receptors are expressed at a lower level at
the mRNA (Figure 1A) and at the protein level (Figures 5A,B), and
accordingly that the deficient cells produce less IFNγ in response
to stimulation with IL-12 and IL-18 in the absence of accessory
cells (Figures 5C,D). CD25 upregulation in response to IL-12 was
also impaired in PLZFlu/lu iNKT thymocytes, while they retained
the ability to respond to TCR stimulation (Figure 5E).
PLZF also regulates a cluster of genes involved in T cell help to
B cells. This cluster includes ICOS, CD40L, c-Maf (as shown here)
as well as a number of cytokines (Kovalovsky et al., 2008; Sav-
age et al., 2008). Both iNKT (Leadbetter et al., 2008) and γδNKT
(Felices et al., 2009) cells can provide help to B cells and induce
immunoglobulin class switching; our results suggest that PLZF
may regulate this important function.
The transcription factor ThPOK (encoded by Zbtb7b) was
found among genes regulated by PLZF in TCR transgenic mice
(Figure 1A). ThPOK – a BTB-POZ family member that regu-
lates CD4 T cell development – was recently shown to be required
for development of iNKT (Engel et al., 2010; Wang et al., 2010)
and γδNKT (Alonzo et al., 2009; Park et al., 2010) cells. How-
ever, in TCR non-transgenic mice no consistent difference in
ThPOK expression between PLZF+/+ and PLZFlu/lu NKT cells
was observed (Figure A2B in Appendix), suggesting that regula-
tion of ThPOK expression by PLZF does not play a non-redundant
role under physiological conditions.
We found evidence for PLZF haploinsufficiency. On the level
of transcription, for the vast majority of genes either upregu-
lated or downregulated in PLZF-deficient cells, heterozygous cells
showed an intermediate level of expression (Tables S1 and S2 in
Supplementary Material). ICOS expression level was also interme-
diate in heterozygous cells at the periphery (Figures 4B,D), and
in fact within a single animal showed a direct relationship with
the level of PLZF expression (Figure 4A), suggesting that PLZF
was a limiting factor in the regulation of ICOS expression. Het-
erozygous animals also showed an intermediate phenotype with
respect to NKT cell numbers in the thymus and at the periph-
ery, as well as their maturation state (Figure A1 in Appendix),
showing that in this respect PLZF expression is also a limiting
factor.
PLZF is expressed by cells that are thought to be selected by ago-
nist ligands (Baldwin et al., 2004; Moran et al., 2011), and can be
induced in vitro by strong TCR signaling (Kreslavsky et al., 2009).
Strong TCR signal is also required for commitment to the γδ T cell
lineage. In the absence of strong TCR signal, γδTCR-expressing
cells can be diverted to the αβ T cell lineage, as evidenced by their
progression to the CD4+CD8+ stage (Haks et al., 2005; Hayes
et al., 2005; Lauritsen et al., 2009). It was thus possible that PLZF
might play a role in commitment to the γδ lineage – at least for
Vγ1Vδ6.4 T cells. However, the frequency of double positive cells
was unchanged in Vγ1Vδ6.4 TCR transgenic mice on a PLZF-
deficient background, suggesting that PLZF has little or no impact
on the αβ versus γδ lineage decision.
The increased percentage of NK1.1lo CD44lo CD1d tetramer-
positive cells in the thymi of PLZF-deficient mice has led to a
conclusion that PLZF-deficient NKT cells are developmentally
blocked at stage 1 of their development (Savage et al., 2008).
We note, however, that the CD44/NK1.1 staining pattern in the
absence of PLZF appears diffuse, with a significant proportion
of NK1.1+ CD44lo cells which are not found in wt or heterozy-
gous animals (Figure A1A in Appendix). Such a pattern may
indicate a dysregulation of marker expression, rather than a spe-
cific block. Corroborating this idea is the presence of a significant
number of CD1d tetramer-positive cells at the periphery in PLZF-
deficient animals (Figures A1B,C in Appendix, top panels) – if
truly blocked, thymocytes should not gain the capacity to leave the
thymus. Some cells in the periphery appear mature according to
NK1.1/CD44 staining (Figures A1B,C in Appendix, lower panels).
Finally, the PLZF-deficient cells can produce IFNγ, albeit at a lower
level (Kovalovsky et al., 2008; Kreslavsky et al., 2009) – a prop-
erty normally acquired at stage 2 – indicating that although they
may not have passed through all of the appropriate phenotypic
stages, they have indeed progressed past stage 1. Thus, our and
others’ data may challenge the notion that PLZF-deficient iNKT
and γδNKT in the periphery are completely naïve – conversely,
they may represent cells that were able to partially compensate for
the deficiency.
We cannot ascertain whether the genes we describe are reg-
ulated by PLZF directly or indirectly. Indeed, the list of genes
whose expression is affected by the presence or absence of PLZF
includes several encoding known transcription regulators in addi-
tion to Maf and Id2 – including Rora, Lmo4, and Npas2. We note,
however, that Id2 has been shown to be a direct target of PLZF
in another setting (Doulatov et al., 2009), and that the strong
correlation between the levels of ICOS and PLZF expressed by
individual cells may also suggest a direct relationship between
the two.
Our data demonstrate that PLZF controls, either directly or
indirectly, the expression of a small set of genes, highly enriched
for immune function. This includes molecules known to function
in NKT cells – c-Maf, Id2, and ICOS, as well as the proinflammatory
cytokine receptors IL12Rb1 and IL18R1. Thus, PLZF orchestrates a
part of innate-like phenotype of NKT cells via a set of target genes
that together can partially explain the defects in cytokine secretion,
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FIGURE 5 | PLZF regulates the expression of receptors for IL12 and IL18.
Thymocytes from mixed chimeras with wt (CD45.1) and PLZFlu/lu (CD45.2) bm
were stained with PBS-57-loaded CD1d tetramers and antibodies against the
indicated surface markers. Expression of IL12Rb1 (A) and IL18R1 (B) on total
iNKT cells (TCRβ+CD1d-Tet+) (left), stage 0/stage 1 iNKT cells
(CD44-NK1.1-TCRβ+CD1d-Tet+) (center) and γδNKT (TCRγδ+Vδ6.3+) cells
(right) is shown (staining for iNKT and γδNKT cells were performed
independently). Representative FACS plots from one of three independent
experiments are shown. 50,000 sorted CD4+CD8− thymocytes from PLZF+/+
and PLZFlu/lu Rag1−/−Vγ1Vδ6.4 TCR transgenic animals (C) or 4000 sorted
thymic iNKT cells (TCRβ+CD1d-Tet+) from wt and PLZFlu/lu mice (D) were
stimulated with IL12 and IL18 for 48 h or left unstimulated. Production of IFNγ
was measured by ELISA. (E) CD25 expression by wt and PLZF-deficient cells
in response to IL-12 or anti-CD3 treatment.
survival, co-stimulation and responsiveness to proinflammatory
cytokines observed in PLZF-deficient NKT cells. The finding that
not all of the features of the NKT phenotype can be attributed to
PLZF points to the importance of other factors in regulating the
unique innate-like properties of and γδNKT and iNKT cells.
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APPENDIX
FIGURE A1 | Surface phenotype of iNKT cells from PLZF+/+, PLZFlu/+ and
PLZFlu/lu mice. Cells from thymi (A), spleens (B), and livers (C) of mice with
indicated genotype were isolated and stained with PBS-57-loaded CD1d
tetramers and antibodies against TCRß, CD24, CD44 and NK1.1.
FIGURE A2 | Expression of Maf (A) and Zbtb7 (B) mRNA analyzed by
TaqMan RT-PCR. Cells from thymi or spleens of mice with the indicated
genotype were isolated and stained with PBS-57-loaded CD1d tetramers and
antibodies against TCRβ, CD24, CD44 and NK1.1. iNKT, γδNKT or CD4 single
positive were sorted, mRNA was extracted, and subjected to RT-PCR. Error
bars represent SD from independent mice.
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